Catalyst Wire Dossier Catalyst Wire Dossier

TOBREX

TOBRAMYCIN · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TOBREX, covering 2012-03-06 to 2021-05-14. Get the full timeline:

Most recent: FDA Approved: TOBREX — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing